TIMD4 and ovarian cancer: In conclusion, based on Tim-4 (or CRIg in humans), we have identified 2 ontogenically, phenotypically, metabolically, and functionally distinct peritoneal macrophage subsets in ovarian cancer (see graphical abstract).